Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 35 of 95, showing 5 Applications out of 471 total, starting on record 171, ending on 175

# Protocol No Study Title Investigator(s) & Site(s)

171.

ECCT/21/07/01   RESOLVE
    A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell DiseaseA Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
2. Jessie Nyokabi Githanga
Site(s) in Kenya
1. Strathmore University Medical Center (Nairobi City county)
2. KEMRI Kondele children\'S Hospital (Kisumu county)
3. Gertrude\'s Children\'s Hospital (Nairobi City county)
 
View

172.

ECCT/21/06/15   Therapeutic Efficacy Study
    Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the treatment of uncomplicated Plasmodium falciparum malaria in Siaya and Bungoma counties, Kenya.   
Principal Investigator(s)
1. Dr. Sarah-Blythe Ballard
2. Dr. Willis Akhwale
3. Dr. Grace Ikahu
4. Dr. George Githuka
5. Dr. Dickson Mtungu Mwakangalu
6. Dr. Elvis Omondi Oyugi
7. Hellen Gatakaa
8. Regina Jepkosgei Kandie
9. Dr. Fredrick Ouma Odhiambo
Site(s) in Kenya
1. Mahonge Health Center (Bung\'oma county)
2. Kaluo Health Center (Siaya county)
 
View

173.

ECCT/21/06/14   CoVPN 3008
    Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Kisumu Clinical Research Site (Kisumu county)
 
View

174.

ECCT/21/06/13   CARES
    A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety,   and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine   From Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults   in Sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
3. Aga khan University Hospital (Nairobi City county)
 
View

175.

ECCT/21/06/12   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the   efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein   Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age   and older   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. Kenya Medical Research Institute (Kisumu county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Nairobi City county)
7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Bung\'oma county)
 
View